Both in Biotechnology
Vor Biopharma vs Odyssey Therapeutics
Over the past year VOR returned −10.9% and ODTX returned −12.4%; their daily moves had a correlation of 0.52.
VOR −10.9% ODTX −12.4%Growth of $1, one year, split-adjusted
| Metric | VOR | ODTX |
|---|---|---|
| Price | $19.86 | $21.57 |
| Market cap | $1.22B | $1.04B |
| Today | +3.17% | +10.45% |
| 1 month | +6.9% | +3.5% |
| 6 months | +28.0% | — |
| Year to date | +51.8% | — |
| 1 year | −17.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 0.9× | — |
| Price / sales | — | — |
| Net cash | $481.6M | $310.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | — |
| Short % of float | 17.6% | 13.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).